Item 1A. Risk Factors
2K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors
There have been no material changes from the risk factors disclosed in Item 1A of our 2024 Annual Report on Form 10-K.
| ConocoPhillips 2025 Q1 10-Q | 52 |
| Table of Contents |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
| Millions of Dollars | ||||||||||||||
| Period | Total Number of Shares Purchased* | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs | ||||||||||
| January 1 - 31, 2025 | 3,692,650 | $ | 102.91 | 3,692,650 | $ | 30,348 | ||||||||
| February 1 - 28, 2025 | 4,961,865 | 98.75 | 4,961,865 | 29,858 | ||||||||||
| March 1 - 31, 2025 | 6,467,559 | 97.41 | 6,467,559 | 29,228 | ||||||||||
| 15,122,074 | 15,122,074 |
*There were no repurchases of common stock from company employees in connection with the company's broad-based employee incentive plans.
In late 2016, we initiated our current share repurchase program. As of March 31, 2025, we had repurchased $35.8 billion of shares since 2016. In October 2024, our Board of Directors approved an increase from our previous authorization of $45 billion by a total of the lesser of $20 billion or the number of shares issued in our acquisition of Marathon Oil, such that the Company is not to exceed $65 billion in aggregate repurchases. Repurchases are made at management’s discretion, at prevailing prices, subject to market conditions and other factors. Except as limited by applicable legal requirements, repurchases may be increased, decreased or discontinued at any time without prior notice. Shares of stock repurchased under the plan are held as treasury shares. See Part I—Item 1A—Risk Factors – “Our ability to execute our capital return program is subject to certain considerations” in our 2024 Annual Report on Form 10-K.
Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information